GSK begins dosing in phase III study of sirukumab for treatment of giant cell arteritis
GCA is characterized by the inflammation of large and medium-sized arteries, mostly in the head and neck, which occurs in people aged 50 or older. Under the study,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.